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Abstract
Background: Apolipoprotein E, a component of the plasma lipoproteins, plays an important role in the transport
and metabolism of cholesterol and other lipids. Three single nucleotide polymorphisms (SNPs) -491A>T, -219T>G
and +113G>C in the regulatory region of human apolipoprotein E gene (APOE) change the promoter activity and
are associated with a wide variety of disorders including Alzheimer disease (AD). Functional SNPs in porcine APOE
gene 5’ regulatory region have not been explored.
Results: We examined SNPs within this region (from -831 to +855), and the analysis revealed that the T>A SNP at
position -155 among these three polymorphism sites (-440, -155, +501) was found to exert a marked influence on
the transcription of the porcine APOE gene. Electrophoretic mobility shift assays showed that the binding affinity of
oligonucletides containing the -155A to transcription factor(s) was stronger than that of the -155T. Transient
transfection assays and quantitative real-time PCR results revealed that the -155T>A variant enhanced the activity
of the APOE promoter and was associated with increased APOE mRNA levels in vivo.
Conclusions: These data suggest that the -155T>A mutation in the promoter region of the porcine APOE gene is
an important functional variant. The results provided new insights into aspects of pig genetics and might also
facilitate the application of pigs in biomedical studies addressing important human diseases.
Background
Apolipoprotein E (apoE = protein; APOE =g e n e )i sa
component of lipoproteins, and thereby regulates lipo-
protein metabolism; apoE also plays a key role in main-
taining neuronal integrity [1-4]. Utermann et al. [5]
were the first to identify three isoforms of human apoE,
named E2, E3, and E4. The allele encoding apoE4 is a
risk factor for atherosclerosis [6,7], and AD [1,8,9]. In
addition, humans with E4 allele responded to a lipid-
lowering therapy poorly whereas those with E2 allele
sensitively [10]. There are four single nucleotide poly-
morphisms (SNPs) at -491, -427, -219 and +113 in
human APOE promoter [11-13]. The base substitutions
at -491A>T and -219T>G were found to alter promoter
activity and transcription factor binding affinity
[12,14,15]. The -491SNP and -219SNP were related to
different plasma apoE [16], LDL and cholesterol
concentrations [17], and the risks of atherosclerosis [16]
and AD [14,15]. Furthermore, +113SNP modulated
lipid, lipoprotein concentrations and aortic atherosclero-
sis [11,13]. However, there were inconsistent reports
about APOE polymorphisms and coronary heart disease
[18] or AD [19-21].
In pigs, APOE has been mapped to chromosome 6
[22,23]. Porcine APOE is 4267 nucleotides in length,
comprising of four exons and three introns, and a (CG)
13 microsatellite located within intron 3 [24]. Addition-
ally, Brzozoeska et al. [25] studied the cDNA sequence
of porcine APOE,a n dK u r y ł [23] described three iso-
forms of porcine apoE. Fan et al. [26] recently demon-
strated that a SNP within intron 2 of porcine APOE was
associated with body conformation traits. However, the
functional SNPs in the 5’ regulatory region of porcine
APOE remain unclear.
To identify the functional SNPs in the 5’ regulatory
region of porcine APOE, mRNA expression levels and pro-
moter activities associated with different genotypes were
analyzed with quantitative RT-PCR (qRT-PCR) and transi-
ent transfection assays respectively, potential cis-acting
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trophoretic mobility shift assays (EMSAs). Our results
indicate that the -155 SNP modulates the expression level
of porcine APOE.
Results
Screening for SNPs in the APOE 5’ regulatory region
Three overlapping fragments from -831 to +855 (1686 bp)
were amplified. Three SNPs were identified in this region:
-155T>A, -440G>A, and +501A>T.
A SNP",1,0,1,0,0pc,0pc,0pc,0pc>Genotype frequencies of
-155T>A SNP
The genotypic frequencies of -155SNP were listed in
Table 1. The frequencies were highly significant among
different genotypes within the breeds (P <0 . 0 1 ) ,b u t
not significantly different (P > 0.05) between the
breeds.
Alternations of predicted transcription factor binding
sites surrounding porcine APOE SNPs
The three polymorphic sites were examined with MatIn-
spector http://www.genomatix.de[27]. Results revealed
that the mutation -155 T>A lost the transcription factor
sites for GAGA, KLF6, PURa, KKLF, cKROX and MAZ,
and gained sites for BKLF and CTCF (additional file 1),
while the other two (-440G>A, and +501A>T) did not
show changes (data not shown).
Alignment of porcine and human APOE promoter
sequences
We aligned porcine and human APOE promoter
sequences. The homology of the proximal promoter
regions between human APOE from -236 to +10 and
porcine APOE from -265 to -12 was of greater similar-
ity (69.1%) than those of -266 or more upstream of
porcine APOE, and a TATA box was found in the two
sequences (Figure 1), which suggested functional
importance of these fragments across the two species.
There is a functional mutation -219T>G in human
APOE [12], and the -155T>A of porcine APOE changes
the potential transcription factor binding sites (addi-
tional file 1). Thus -155T>A mutation was further
studied.
Effects of -155 mutation on APOE mRNA levels
To determine whether -155T>A was associated with dif-
ferential APOE expression in vivo, hepatic mRNA levels
of adult Dahuabai pigs were analyzed with qRT-PCR.
The results revealed that mRNA levels of -155AA ani-
mals were approximately 11 times higher than those of
-155TT animals (Figure 2).
The -155SNP effects on APOE transcription
We used the porcine APOE promoter region spanning
-268 to -11 to assemble fusion constructs of the APOE
promoter and a firefly luciferase reporter. As shown in
Figure 3, the promoter with -155A allele was signifi-
cantly better at driving luciferase expression, and
reporter levels were 6.7-time higher than that with
-155T.
Table 1 Genotype frequencies of the porcine APOE -155
SNP in different populations.
Breed N Genotype
TT TA AA
Dahuabai 58 20(0.34) 30(0.52) 8(0.14)
Lantang 50 22(.44) 24(0.48) 4(0.08)
Yorkshire 51 26(0.51) 19(0.37) 6(0.12)
Landrace 50 24(0.48) 25(0.50) 1(0.02)
N, Number of animals.
Figure 1 Homology of human APOE and porcine APOE
promoter. The porcine promoter sequence (225 bp) (U70240.1) was
aligned with the proximal-most 245 bp of human APOE sequence
(AF261279). The similarity is 69.1%. Positions of the “TATA” box and
the -155SNP site are indicated.
Figure 2 The T>A transition at position -155 in the porcine
APOE promoter region increases mRNA levels in Dahuabai
pigs. Data are expressed as means ± S.E.. The mRNA levels of
different genotypes differ P < 0.01.
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interactions",1,0,1,0,0pc,0pc,0pc,0pc>Impact of the
-155T>A mutation on DNA-protein interactions
EMSAs were performed to understand whether the dif-
ferential promoter activities were related to changes in
protein binding. As shown in Figure 4, incubation of
nuclear extract with the probe corresponding to the
-155T or -155A allele predominantly formed a specific
binding complex (lane 2 of Figure 4A and 4B, arrowed).
The binding complex of -155T probe with transcrip-
tional factor(s) was largely abolished by co-incubation
with an excess of either unlabelled -155T or -155A allele
probes (lanes 3-6 of Figure 4A). By contrast, the com-
plex formed by incubation of nuclear extract with the
-155A probe was largely eliminated by co-incubation
with unlabelled -155A competitor (lanes 3, 4 of Figure
4B) or unlabelled 50-fold excess -155T probe (lane 6 of
Figure 4B), whereas a conspicuous complex formation
was observed in the presence of unlabelled 10-fold
excess -155T competitor (lanes 5 of Figure 4B). The
results indicated that -155A allele can greatly enhance
the binding affinity of transcriptional factor(s).
Discussion
This study identified a functional SNP in the 5’ regula-
tory region of porcine APOE. The behaviours of the
allelic forms of the reporter gene expression, real-time
PCR and EMSA in our study strongly suggested that
-155T>A allelic differences of the APOE transcription
may be a consequence of differential binding ability of
transcriptional factors or differential transcriptional fac-
tors bound to a wild type or a mutation type present in
cells.
To distinguish potentially functional SNPs from non-
functional SNPs, we focused on cis-acting elements
based on the suggestion of Knight [28] and used a pre-
dictive program http://www.genomatix.de[27]. The
results indicated there were different transcription fac-
tors binding the cis-acting elements surrounding the
-155SNP (additional file 1). The -155T contains a
CCCTCCC motif that is known as the SP1 binding site
[29], and SP1 has been implicated for its function in
regulating AD-associated genes [30]. Meanwhile, the
mutation at porcine APOE -155 site still had SP1 bind-
ing ability.
The existence of multiple transcription factors binding
the -155 region was further reinforced by incubation of a
-155T/A DNA probe with nuclear extracts from porcine
fetal fibroblasts forming DNA-protein complexes as
demonstrated by EMSA. Importantly, competition EMSA
using excess unlabelled probes revealed a difference in
the binding affinities of promoter alleles: excess -155A
DNA cold probe effectively abolished complex formation,
whereas 10-fold excess -155T DNA cold probe failed to
prevent labelled -155A probe-protein complex formation.
From the above results, we could consider that the -155A
promoter had a significantly higher affinity for binding
factors than that for the -155T promoter. Interestingly,
for human APOE -491A>T mutation, the -491A dis-
played an increased affinity for human hepatic nuclear
proteins [14], while the -491A showed an opposite trend
for rat pheochromocytoma and human SK-N-SH neuro-
blastoma nuclear proteins [15].
It was demonstrated, in transfected cells, that the
cloned promoter containing the -155A variant was sig-
nificantly stronger than that of the corresponding -155T
variant at driving luciferase expression (6.7-fold higher
expression, P < 0.01). The cloned promoter in this
Figure 3 Functional analysis of porcine APOE promoter alleles
containing -155T or A. Data are expressed as means ± S.E.. The
activity of the -155A promoter is significantly (P < 0.01) higher than
that of -155T.
Figure 4 The T>A transition at position -155 of the porcine
APOE gene increases DNA-binding affinity of nuclear protein(s)
in porcine fetal fibroblasts. Electrophoretic mobility shift assays
were carried out as described in Materials and Methods. Protein-
DNA complexes were separated on 5% PAGE and exposed to X-ray
film. In competition experiments (lanes 3-6), Nuclear extracts were
preincubated in the absence (-) or 10-fold excess (+) or 50-fold
excess (++) of unlablled competitor before addition of the
32P-
labelled probe. Binding complexes identified with the -155T probe
and -155A probe were indicated with arrows.
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fied polymorphic sites (-440 and +501). The difference
in transcription efficiency was confirmed in vivo,a n d
APOE mRNA levels were 11 times higher in liver tissue
from -155AA homozygous pigs than that in the tissue
from -155TT homozygotes (P < 0.01). In the report of
Maloney et al. [15], human -491A>T variant interacted
with -219G>T because both mutations altered the vari-
ety and binding affinity of transcription factors. How-
ever, the -401SNP and +501SNP in porcine APOE were
not expected to change the transcription factors, which
implied that there may be no interactive effect between
porcine APOE -155SNP and the other two SNPs.
A l lt h e s ed a t as u g g e s tt h a tp o l y m o r p h i s ma tS N P - 1 5 5
modulates transcription of the porcine APOE gene by
affecting the ability of the APOE promoter to bind to
trans-acting factors. It is notable that the -155 T>A substi-
tution alters the CCCTCCC sequence to CCCACCC. The
CACCC box is a well-described cis-acting transcription
element that can serve as a binding site for widely distribu-
ted transcription-activating factors that act collaboratively
w i t ho t h e rr e g u l a t o r yp r o t e i n s[ 3 1 ] .T h e r ea r eal a r g e r
family of zinc finger transcription factors bound to
CACCC box [32]. Mutation of this box is thought to
change binding and transactivation by transcription factors
and therefore to decrease transcription levels [33-36].
Our results suggest that the -155A allele is associated
with increased levels of APOE transcription in vivo.I t
seems probable that the -155A variant can elevate levels
of apoE protein. We also report that the frequency of
the -155AA genotypes is significantly under-represented,
compared to -155TT and -155TA, in each of the four
different pig populations analyzed. Although the expla-
nation for this depletion is unknown, there are several
considerations as follows.
Firstly, it was previously reported that apoE enhanced
cell lipid homeostasis [17,37] and could reduce the risk
of heart disease [16,38]. In humans, the concentration of
apoE in plasma or brain varies according to APOE geno-
type in the order E2 > E3 > E4 [37], and the E4 allele is
an established risk factor for AD. The -491A allele of
human APOE is also a risk factor for AD, but this func-
tion is associated with higher levels of APOE transcrip-
tion versus the -491T allele, and these effects are exerted
independently of E4 [14]. In the experiments reported
here we found that the -155A allele was associated with
significantly increased transcription of porcine APOE
both in transfected cells and hepatic tissue. Higher apoE
concentration lead to increased cytotoxicity [39], thus
-155A allele may be harmful to porcine survival.
Secondly, some recessive genes that terminate fetal
development are known to be located on swine chromo-
some SSC6 between SW855 and SW122 [40], a region
that includes the porcine APOE gene [22,40]. The
affected gene(s) in the homozygous state can prevent
embryo development after 9 days post-coitus when the
spherical embryo grows to the filamentous form, leading
to embryonic death due to implantation failure [40].
This suggests that under-representation of -155AA
could be a consequence of linkage disequilibrium
between porcine APOE and other genes in the vicinity.
Conclusions
We have identified a functional SNP in the regulatory
region of the porcine APOE gene that was associated
with altered interactions with DNA-binding factors,
marked differences in the activity of the APOE promoter
and levels of APOE mRNA in vivo.
Methods
Screening for porcine APOE 5’ regulatory SNPs
All animal procedures were performed according to pro-
tocols approved by the Biological Studies Animal Care
and Use Committee of Guangdong Province, China. Ear
tissues of Landrace, Yorkshire, Chinese indigenous
breed Lantang and Dahuabai pigs were used for geno-
mic DNA isolation according to Sambrook and Russell
[41]. Primers (Table 2) for three overlapping segments
were designed with Primer Primer 5.0 according to por-
cine APOE sequence (GenBank: U70240.1). The PCR
products were sequenced and genotyped.
Real-time quantitative PCR
Total RNA was extracted from the hepatic tissue of adult
Dahuabai pig (-155TT, -155TA, -155AA, 6 animals of
each of the three genotypes) with TRIzol reagent (Invitro-
gen). QRT-PCR analysis was performed using the ABI
7500 system (Applied Biosystems) (primers: 5’-CGCAG-
GATGCCGGACAGA-3’ and 5’-CCTCCTGCACTTGGT-
CAGACA-3’) .T h eg e n ee x p r e s s i o nl e v e l sw e r eq u a l i f i e d
relative to the expression of b-actin by the comparative CT
method [42].
Plasmid constructions
The DNA segment spanning the -268 to -11 region of
porcine APOE and containing either the -155T or
-155A variants was amplified with the primers 5’-
CACGCGTAGTGGCATGGAGAAA-3’ and 5’-A CTC-
GAGACTCCTCCAGAACT -3’, thereby creating the
restriction sites of MluIa n dXhoI (underlined). Follow-
ing restriction enzyme digestion the PCR products
were inserted to vector pGL3-basic (Promega). The
integrity of cloned sequences was confirmed by
sequencing.
Transient transfection assays
Porcine fetal fibroblast cell line was established as
described previously [43]. Cells (1.5 × 10
6 per well) were
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Page 4 of 6seeded into 96-well plates and grown to 80-90% conflu-
ence, and transfected with APOE promoter/firefly luci-
ferase reporter plasmids by Lipofectamine 2000
transfection reagent (Invitrogen). To control for trans-
fection efficiency, cells were co-transfected with 2 ng of
Renilla luciferase reporter plasmid (Promega). After 48
h of transfection, cells were lysed and assayed for pro-
moter activity using the dual luciferase reporter assay
system. Firefly luciferase activity was expressed relative
to Renilla luciferase activity.
Electrophoretic mobility shift assays
Nuclear proteins were extracted from porcine fetal
fibroblast cells cultured at third passage (Nuclear Extract
Kit, Active Motif). The sequences used for EMSAs were
5’-CCCCTCCCCC(T/A)CCCTGCTGTGTG-3’ sur-
rounding the -155 site. The oligonucleotides were 5’-
labeled with [g-
32P]-ATP using a Megalabel DNA 5’-
labelling Kit according to the specifications of the man-
ufacturer (Takara). The 5’-labelled probes used in subse-
quent experiments were double stranded.
T h eb i n d i n gm i x t u r ei n c l u d e d0 . 5μgp o l y( d I - d C )
(Amersham Biosciences), 2 μl of 5 × gel-shift binding
buffer, 2 μg of nuclear extract. The mixture was main-
tained at room temperature for 10 min, 2 μl of radiola-
belled oligonucleotide probe was added, and incubation
was kept for a further 20 min at room temperature in
the presence or absence of a 10- to 50-fold molar excess
of unlabelled probes. DNA-protein complexes were frac-
tionated by electrophoresis on 5% non-denaturating
polyacrylamide gels.
Data analysis
For continuous data, comparisons of two means
employed independent t tests, q values were calculated
for comparisons of three means. Genotype frequencies
were analyzed with probit models [44].
Additional material
Additional file 1: Transcriptional factors surrounding -155SNP
predicted by MatInspector.
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